Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor

Journal of the American Society of Nephrology

Volumn 9, Issue 10, 1998, Pages 1873-1880

  Carlson, Sara G ^a   Eng, Eudora ^a   Kim, Eung Gook ^a   Peruvian, Elizabeth J ^a   Copel, Terry D ^a   Ballermann, Barbara J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE 2A;

ANIMAL CELL; ARTICLE; CATTLE; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; KIDNEY DEVELOPMENT; KIDNEY EPITHELIUM; MORPHOGENESIS; NEPHROBLASTOMA; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0031685285     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G,: can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: Characterization of the set gene. Mol Cell Biol 12: 3346-3355, 1992
2. Kim E-G, Choi ME, Ballermann BJ,: Spatially restricted expression of ,set mRNA in developing rat kidney. Am J Physiol 266 [Renal Fluid Electrolyte Physiol 35]: F155-F161, 1994
3. Adachi Y, Pavlakis GN, Copeland TD,: Identification of in vivo phosphorylation sites of SET, a nuclear phosphoprotein encoded by the translocation breakpoint in acute undifferentiated leukemia, FEBS Lett 340: 231-235, 1994
4. Li M, Makkinje A, Damuni Z,: The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A, J Biol Chem 271: 11059-11062, 1996
5. Mumby MC, Walter G,: Protein serine/threonine phosphatases: Structure, regulation, and functions in cell growth, Physiol Rev 73: 673-699, 1993
6. Wera S, Hammings BA,: Serine/threonine protein phosphatases, Biochem J 311: 17-29, 1995
7. McCright B, Rivers AM, Audlin S, Virshup DM,: The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both the nucleus and cytoplasm, J Biol Chem 271: 22081-22089, 1996
8. Cayla X, Van Hoof C, Bosch M, Waelkens E, Vandekerckhove J, Peelers B, Merlevede W, Goris J,: Molecular cloning, expression, and characterization of PTPA, a protein that activates the tyrosyl phosphatase activity of protein phosphatase 2A, J Biol Chem 269: 15668-15675, 1994
9. Sontag E, Fedorov S, Kamibayashi C, Robbins D, Cobb M, Mumby M,: The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the MAP kinase pathway and induces cell proliferation, Cell 75: 887-897, 1993
10. Haystead CMM, Gregory P, Shirazi A, Fadden P, Mosse C, Dent P, Haystead TAJ,: Insulin activates a novel adipocyte mitogenactivated protein kinase kinase kinase that shows rapid phasic kinetics and is distinct from c-raf, J Biol Chem 269: 1280412808, 1994
11. Bialojan C, Takai A,: Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases, Biochem J 256: 283-290, 1988
12. Haystead TAJ, Sim ATR, Carling D, Honnor RC, Tsukitani Y, Cohen P, Hardie DG,: Effects of the tumor promoter okadaic acid on intracellular protein phosphorylation and metabolism, Nature 337: 78-81, 1989
13. Clarke PR, Hoffmann I, Draetta G, Karsenti E,: Dephosphorylation of cdc25-C by a type-2A protein phosphatase: Specific regulation during the cell cycle in Xenopus egg extracts, Mol Biol Cell 4: 397-411, 1993
14. Goris J, Hermann J, Hendrix P, Ozon R, Merlevede W,: Okadaic acid, a specific protein phosphatase inhibitor, induces maturation and MPF formation in Xenopus laevis oocytes, FEBS Lett 245: 91-94, 1989
15. Felix M-A, Cohen P, Karsenti E,: Cdc2Hl kinase is negatively regulated by a type 2A phosphatase in the Xenopus early embryonic cell cycle: Evidence from the effects of okadaic acid, EMBOJ9: 675-683, 1990
16. Ballermann BJ,: Regulation of bovine glomerular endothelial cell growth in vitro, Am J Physiol 256: C182-C189, 1989
17. Choi ME, Ballermann BJ,: Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-β receptors, J Biol Chem 270: 2114421150, 1994
18. Carlson SG, Fawcett TW, Bartlett JD, Bernier M, Holbrook NJ,: Regulation of the C/EBP-related gene gaddlSS by glucose deprivation, Mol Cell Biol 13: 4736-4744, 1993
19. Chirgwin JJ, Pryzbyla AE, MacDonald RJ, Rutter WJ,: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry 18: 5294-5299, 1979
20. Davis LG, Dibner MD, Battey JF,: Preparation and analysis of RNA from eukaryotic cells, In: Basic Methods in Molecular Biology, 1st ed., edited by Davis LG, New York, Eisevier Science Publishing Co., Inc., 1986:143-146
21. Church GM, Gilbert W,: Genomic sequencing, Proc Natl Acad Sei USA SI: 1991-1995, 1984
22. Laemmli UK,: Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227: 680685, 1970
23. Adachi Y, Pavlakis GN, Copeland TD,: Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation breakpoint in acute undifferentiated leukemia, J Biol Chem 269: 2258-2262, 1994
24. Dressler GR, Douglass EC,: Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor, Proc Natl AcadSci USA 89: 1179-1183, 1992
25. Garvin AJ, Re GG, Tarnowski BI, Hazen-Martin DJ, Sens DA,: The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney, Am J Pathol 142: 375-380, 1993
26. Zhang H, Xiong Y, Beach D,: Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes, Mol Biol Cell 4: 897-906, 1993
27. Gadbois DM, Peterson S, Bradbury EM, Lehnen BE,: CDK/ cyclin Dl/PCNA complexes during staurosporine-induced Gl arrest and GO arrest of human fibroblasts, Exp Cell Res 220: 220-225, 1995
28. Svennilson J, Durbeej M, Celsi G, Laestadius A, da Cruz e Suva EF, Ekblom P, Aperia A,: Evidence for a role of protein phosphatases 1 and 2A during early nephrogenesis, Kidney Int 48: 103-110, 1995
29. Tagge EP, Hanson P, Re GG, Othersen HB, Smith CD Jr, Garvin AJ,: Paired box gene expression in Wilms' tumor, J Pediatr Surg 29: 134-141, 1994
30. Eccles MR, Yun K, Reeve AE, Fidler AE,: Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors, Am J Pathol 146: 40-45, 1995
31. Paik S, Rosen N, Jung W, You JM, Lippman ME, Perdue JF, Yee D,: Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor: An in situ hybridization study, Lab Invest 61: 522-526, 1989
32. Hirvonen H, Sandberg M, Kalimo H, Hukkanen V, Vuorio E, Salmi TT, Alitalio K,: The N-myc protooncogene and IGF-II growth factor mRNAs are expressed by distinct cells in fetal kidneys and brain, J Cell Biol 108: 1093-1104, 1989
33. Haber DA,: Wilms' tumor, In: Molecular Nephrology, 1st Ed., edited by Schlondorff D, Bonaventre JV, New York, Marcel Dekker, Inc., 1995:783-793
34. Kubota T, Saitoh S, Matsumoto T, Narahara K, Fukushima Y, Jinno Y, Niikawa N,: Excess functional copy of allele at chromosomal region lip 15 may cause Wiedemann- Beck with (EMG) syndrome, Am J Med Genet 49: 378-383, 1994
35. Ryan G, Steele-Perkins V, Morris JF, Rauscher FJ III, Dressier GR,: Repression of PAX-2 by WT1 during normal kidney development, Development 121: 867-875, 1995
36. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III,: Repression of the insulin-like growth factor II gene by Wilms' tumor suppressor WT1, Science 257: 674-678
37. Rupprecht HD, Drummond IA, Madden SL, Rauscher FJ III, Sukhatme VP,: The Wilms' tumor suppressor gene WT1 is negatively autoregulated, J Biol Chem 269:6198-6206, 1994
38. Qian F, Watnick TJ, Onuchic LF, Germino GG,: The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 87: 979-987, 1996